Bevacizab 100 mg Injection

Bevacizab 100 mg Injection contains bevacizumab, an anticancer medicine used for treating certain types of cancer. It is supplied as a 100 mg/4 mL solution for intravenous infusion. The medicine helps inhibit the growth of new blood vessels that supply tumors.

BUY NOW

Category

Bevacizab contains a monoclonal antibody that targets vascular endothelial growth factor, an important factor involved in tumor angiogenesis. By inhibiting this pathway, it can help reduce the blood and nutrient supply that supports tumor growth. The medicine may be used as part of treatment protocols for cancers including colorectal, lung, kidney, ovarian, and cervical cancers. It should be administered by qualified healthcare professionals in an appropriate medical setting according to the prescribed treatment plan.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 100 mg/4 mL
Dosage Form Solution for Infusion
Route of Administration Intravenous Infusion
Pack Size 4 mL Vial
Manufacturer Abbott Healthcare Pvt. Ltd.

Product Also Known As

Bevacizab 100 mg Injection, Bevacizab 100 mg/4 mL Injection, Bevacizumab 100 mg Injection, Bevacizumab Infusion, Bevacizab Cancer Injection, Bevacizumab Anticancer Injection